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Abstract 
Introduction: University of Utah Health is an academic health care system that serves residents in Utah and beyond. Clinical 
pharmacists with the health care system’s pharmacy primary care services (PPCS) team provide medication education, population -
based care, and medication management through collaborative practice agreements. With the expansion of clinical pharmacist and 
technician positions and services, the need to measure and assess the impact of pharmacy services and create a value proposit ion for 
internal and external stakeholders became an important goal, and the decision was made to better align practices across all PPCS sites. 
This paper highlights University of Utah Health’s approach to implement comprehensive medication management (CMM) across all 
primary care clinics with embedded clinical pharmacy staff and subsequent evaluation of implementation fidelity.  
Methods: Implementation of CMM was assisted by participation in the National A3 Collaborative and by using selected principles from 
the Active Implementation Framework. Stages of implementation included exploration, instillation, and initiating improvement cycles. 
An implementation team consisting of PPCS employees was created to help with standardization, developing implementation plans, 
and creating a dissemination strategy for all PPCS team members. The CMM care process was subsequently presented and 
implemented by clinical pharmacists in primary care clinics. Following implementation, fidelity measures were collected including 
identification and resolution of medication therapy problems (MTPs) and responses from a questionnaire distributed to the clinical 
pharmacists to self-report understanding and implementation of CMM key elements. The number and type of MTPs identified were 
tracked over 18 months.  
Results: Within the measurement window, clinical pharmacists identified 17,953 MTPs. Of the total number of MTPs identified, 21% 
were related to indication, 53% to efficacy, 15% to safety and 11% to adherence. The questionnaire was distributed to clinical 
pharmacists 9 months after CMM implementation, with a 71% response rate. Pharmacists reported “always” or “often” performing 
each step in the patient care process as follows: indication (93%), effectiveness (93%), safety (87%), and adherence (93%). Reported 
barriers to implementation of the CMM include lack of time to complete all aspects of the process efficiently, lack of a standardized 
format for documentation, and changing practice habits. 
Conclusion: Implementation of a CMM process within University of Utah Health’s PPCS services with the help of a national collaborative 
and implementation framework yielded identification of 17,953 MTPs over 18 months and foundational fidelity to core principles. 
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Introduction 
University of Utah Health is an academic health care system 
located in Utah that serves residents in the state and beyond 
via 14 community clinics, 4 hospitals, and more than 5,000 
health care professionals. As a part of University of Utah Health, 
Pharmacy Primary Care Services (PPCS) consists of 17 clinical 
pharmacists, 4 primary care pharmacy residents, and 7 clinical 
pharmacy technicians embedded into 16 primary care 
practices. These professionals contribute to the primary care 
team by providing patients and health care providers with 
medication education, transitions of care support, population- 
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based care, and medication management using collaborative 
practice agreements. Clinical technicians support pharmacist 
practitioners with administrative and patient care duties 
including managing referrals, assisting with medication 
affordability, and contacting patients for follow up regarding 
disease state management.   
 
In 2017, after considerable expansion of pharmacists, 
technicians and location of practices, driven largely by internal 
recognition of pharmacist impact, PPCS leaders and 
practitioners noted that variation existed between primary care 
practice sites resulting in inconsistent services, unreliable 
outcomes, and limited efficiency. For example, some 
practitioners focused their time more on single disease 
management services while others had developed more 
comprehensive practices as they established stronger 
relationships with primary care providers and patients. Other 
concerns included location of services provided and varying 
degrees of integration into the medical practice to provide 
team-based care. Finally, following the expansion of the 
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number of pharmacist and technician positions, the focus on 
tracking solely activities performed, time spent, and patient 
outcomes was shifted to the need to measure and assess value 
of pharmacy services for internal and external stakeholders. 
Recognizing that, if unaddressed, these barriers could 
potentially limit future growth and sustainability of the 
provision of patient care services by PPCS pharmacists, the 
decision was made to better align practices across all PPCS 
practice sites.  
 
As a solution, the PPCS team began the process of 
implementing comprehensive medication management (CMM) 
based on the principles of the Active Implementation 
Frameworks (AIFs).1 CMM is defined as a patient-centered 
standard delivered by a clinical pharmacist in partnership with 
a team of health care professionals; practitioners delivering 
CMM ensure each medication taken by a given patient has an 
appropriate indication, is effective for the medical condition, is 
safe for that specific patient, and is adhered to by the patient. 
Medications are deliberately reviewed in this order to assist the 
pharmacist in ensuring each medication is optimized for an 
individual patient. The CMM patient care process also involves 
developing patient medication therapy care plans based on 
goals of therapy.2,3 To help with implementation of CMM, PPCS 
leaders specifically selected principles from the AIFs, which was 
created through a review and analysis of implementation 
science literature, because it had been highlighted as a model 
by previous CMM research teams.1,4 The five AIFs are evidence-
based frameworks that include a usable innovation, 
implementation drivers, implementation stages, improvement 
cycles, and implementation teams.1 PPCS leaders adopted 
CMM as the “usable innovation” to standardize practice and 
align with national efforts encouraging its uptake in primary 
care settings.2-3 Additionally, CMM was selected as an evidence-
based approach which has demonstrated positive outcome in 
previous research in the hope that CMM implementation with 
high fidelity would create similar positive results in a new 
setting.5-8 Implementation of CMM included aspects of all three 
essential CMM components: shared philosophy of practice, 
patient care process, and practice management system.3 This 
paper highlights the approach of University of Utah Health’s 
CMM primary care implementation and evaluation of 
implementation fidelity. 
 
Methods  
Implementation of CMM was assisted by participation in the 
National A3 Collaborative, a learning collaborative to support 
health care organizations implementing CMM services in value-
based payment models, offered by the Alliance for Integrated 
Medication Management, Apexus, and the American Society of 
Health-System Pharmacists.9 PPCS pharmacists engaged in the 
collaborative over the course of two years through in-person 
meetings at national pharmacy conferences, monthly coaching 
calls and tools designed to measure progress and institutional 
change. As previously discussed, selected principles from the 
AIFs were used to help with CMM implementation, including 
the usable innovation (described above), framing via 
implementation stages, determining drivers and cycles of CMM 
adoption and description of the implementation team. This 
CMM implementation project was determined to be exempt 
from institutional review board review due to the quality 
improvement nature of the project.  
 
Stage 1: Exploration 
 
After the gap in standardization and consistency of practice 
noted was identified, the PPCS clinical manager created a CMM 
implementation team comprised of eight PPCS pharmacists in 
March 2017. Additional team members included fourth year 
pharmacy students, clinical technicians and pharmacy residents 
as needed based on the current stages of implementation and 
participant interest. The implementation team met twice 
monthly to develop implementation plans, divide tasks and 
consider a dissemination strategy for all PPCS team members. 
Implementation occurred intentionally within key CMM 
domains including creating a shared philosophy of practice, 
utilization of a consistent patient care process and developing 
similar practice management systems.3 The implementation 
team considered essential CMM implementation drivers 
(described below), accumulated current best practices in the 
institution’s primary care clinics, and considered how to 
motivate primary care pharmacists towards a more complete 
and comprehensive view of the patient and their medications. 
The workgroup also discussed how to organize CMM within the 
clinics to maximize outcomes and identify, track and document 
interventions. As mentioned, participation in the National A3 
Collaborative facilitated the workgroup’s implementation of 
CMM by providing coaching and sharing of successful practices 
from assigned collaborative coaches working in outside 
institutions and bi-annual live team sessions with other 
organizations implementing CMM. See Figure 1 for project 
implementation timeline.  
 
Stage 2: Installation 
 
Examine Implementation Drivers 
 
The CMM implementation team determined that the key 
drivers for this project were associated with a shared 
philosophy of practice and a consistent care process. Initial 
implementation would focus mainly on developing each 
pharmacist’s ability to utilize the CMM patient care process 
consistently and with fidelity. Subsequent efforts in CMM 
implementation would revolve around practice management 
systems.  
 
Develop Practitioner Readiness  
 
The CMM philosophy of practice and patient care process were 
ultimately introduced to the PPCS pharmacist group via 
education at monthly staff meetings beginning in May 2017. 
During these staff meetings, the implementation team 
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presented the CMM patient care process for clinical encounters 
and guidance on appropriate documentation in the electronic 
medical record (EMR). Resources included published literature 
on CMM and those developed by the American College of 
Clinical Pharmacy and the Patient Centered Primary Care 
Collaborative.2,3 Once the foundation was set for the CMM 
philosophy of practice and patient care process, data collection 
tools, such as an MTP tracking tool in the EMR, were created so 
initial measurement of CMM implementation could begin. 
Clinical pharmacists were encouraged to discuss CMM and its 
benefits with the primary care providers at their clinics. While 
many of the daily functions performed within the clinics would 
be unchanged, pharmacists were encouraged to discuss the 
development of more comprehensive practices which would 
necessitate enhanced collaboration with health care teams and 
medical providers.   
 
Develop Fidelity Measures  
 
Based on the identified drivers, two measures were selected to 
assess fidelity to CMM implementation: 1) identification and 
resolution of medication therapy problems (MTPs) and 2) a 
pharmacist questionnaire. Medication therapy problems were 
adopted as a means to assess competency of pharmacists in 
operationalizing the patient care process and were defined 
according to the Pharmacy Quality Alliance (PQA) MTP 
Categories Framework.3,10 Using the EMR, MTP data was 
tracked and collected. The number and type of MTPs identified 
were tracked from September 2017 to February 2019 and the 
resolution of MTPs was tracked from July 2018 to February 
2019. MTP resolution was defined as an action step actually 
taken to address the identified problem, and it was deemed an 
important measure to ensure that patients’ needs regarding 
their medications were fulfilled rather than only noting the 
presence of a problem.  
 
The second fidelity measure built upon the foundation of MTP 
identification and resolution and consisted of a questionnaire 
instrument to self-report understanding and implementation of 
CMM key elements. This instrument was distributed to 
pharmacists in April 2018, 9 months after initial 
implementation. The questionnaire was developed by the 
authors, based on elements in the Patient Care Process for 
Delivering Comprehensive Medication Management 
document, to assess understanding of the core elements of 
CMM, specifically the patient care process and what 
improvements were needed.3 The questionnaire was 
anonymous and distributed electronically, consisting of 
questions to collect demographics, frequency of reporting of 
clinical activities, and assessments of the understanding and 
use of the CMM patient care process via 5-point Likert scale and 
free-text questions (Appendix A).  
 
 
 
 
Stage 3: Initial Implementation 
 
Initiate Improvement Cycles 
 
After the CMM implementation process began, ongoing 
discussion among all clinical pharmacists occurred monthly to 
ensure the process was used consistently across clinics. 
Discussions were held during previously scheduled staff 
meetings to minimize outside time obligations for the PPCS 
team, primarily consisting of didactic presentations, discussions 
with pharmacist feedback and distribution of preliminary 
results of MTP data. Feedback on additional mechanisms to 
support the adoption of CMM and improve patient outcomes 
was informally sought from clinical pharmacists throughout the 
project. Pharmacists also spent time shadowing each other for 
peer review and further standardization, which consisted of a 
half-day shadowing experience using a standardized process 
and documentation form.  
 
Results 
 
Medication Therapy Problems (MTPs): 
 
Within the measurement window of 18 months, clinical 
pharmacists identified 17,953 MTPs. Of the total number of 
MTPs identified, 21% were related to indication, 53% to 
efficacy, 15% to safety and 11% to adherence (Figure 2). The 
monthly resolution rate for identified MTPs ranged from 98.0 
to 99.9% from July 2018 to February 2019.  
 
Pharmacist Questionnaire:  
 
Regarding the questionnaire sent to all primary care clinical 
pharmacists and primary care pharmacy residents at the 
institution, 15 of 21 (71%) completed the questionnaire in its 
entirety. Time in practice averaged 5.9 years, and most 
completed PGY1 or PGY2 residency (76 and 53%, respectively) 
and earned board certification (88%). When asked to define the 
CMM patient care process, pharmacists demonstrated they 
understood the comprehensive nature of the care process, as 
most who responded discussed a holistic or systematic 
component of CMM. Pharmacists reported “always” or “often” 
performing each step in the patient care process as follows: 
indication (93%), effectiveness (93%), safety (87%), and 
adherence (93%). Only 60% reported completing those steps in 
the precise order “often” or “always” (Figure 3 and Table 1). 
Pharmacists reported benefits of implementing the process 
included better structuring for learner education, giving more 
organization to patient medication reviews, and being more 
cognizant of a consistent and comprehensive approach to 
medication management. Reported barriers to implementation 
of the CMM care process included lack of time to complete all 
aspects of the process efficiently, lack of a standardized format 
for documentation in the EMR, and changing practice habits.  
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Improvement Cycles: 
 
Several improvements to CMM implementation occurred 
during the project. The majority centered on standardization of 
MTP documentation among clinical pharmacists and increasing 
the number of actual MTPs identified to more accurately 
quantify the effort of the pharmacists. Improvements were also 
made to the MTP data collection tool in the EMR to help with 
efficiency and documentation. Continued effort was devoted to 
encouraging a comprehensive assessment of all medications 
and maintaining fidelity to the CMM patient care process during 
monthly staff meetings. This included sample patient cases 
using the CMM care process, discussions around categorization 
of MTPs and peer review. Improvements were made per 
recommendations of the implementation team in consultation 
with National A3 Collaborative coaches, which included framing 
issues with quality improvement methodology, reinforcement 
of implementation science principles (i.e. fidelity measures, 
etc.), consultation on creating a value proposition for internal 
and external stakeholders, training and onboarding new 
pharmacists and seeking to further define and refine a patient 
population most in need of CMM.   
 
Discussion 
To our knowledge, this is the first study reporting system-wide 
implementation of CMM in a novel environment with attention 
to fidelity measurement. Early implementation of CMM 
showed improvement in adoption of elements of the CMM 
patient care process and the identification and resolution of 
MTPs. Results of the questionnaire revealed that aspects of 
CMM are being utilized by PPCS pharmacists to provide a more 
holistic approach to assessing medications during patient 
interactions, but further efforts are needed in following the 
patient care process consistently. Throughout the 
implementation process team members identified several 
practice changes and tools to enhance implementation of CMM 
including a standardized note template, enhancement of 
existing peer review processes and a more formalized and user-
friendly mechanism for capturing MTPs.  
 
The identification of the majority of MTPs in the indication and 
effectiveness categories is consistent with previous literature; 
however, this institution’s project showed a higher percentage 
of effectiveness problems as compared to previously published 
studies.5-8 These studies have also shown an improvement in 
clinical outcomes and resolution of MTPs, including an increase 
in patients meeting clinical goals as well as reductions in health 
care expenditures.5-8 It is possible that the higher percentage of 
MTPs in the effectiveness category identified in this project was 
due to clinical pharmacists not documenting all possible MTPs, 
which would have resulted in more MTPs in the other 
categories. The lack of documentation could have been caused 
by confusion on whether an identified issue needed to be 
documented, which category to use and how many MTPs to 
document if a high number was identified.  
 
Documenting and tracking MTPs was time consuming and seen 
as additive work as they were not documented into progress 
notes directly but in a separate format that could be traceable 
through reports in the EMR. It was also noticed throughout the 
implementation process that there were variations in 
pharmacist reporting of MTPs, as several interventions may be 
interpreted and categorized differently. Enhancing the capture 
rate of MTPs is an area of continued emphasis. A standardized 
process to document patient progress notes and MTPs in the 
EMR would help the PPCS team use a consistent CMM process 
and make the data more easily retrievable for internal quality 
improvement. 
 
Limitations of the implementation included the utilization of a 
questionnaire that had not been validated although 
constructed from previously published resources.3 Not all 
clinical pharmacists completed the questionnaire meaning key 
information from select individuals was not captured. While 
two potential means to assess implementation fidelity were 
included, these are not complete measures. The focus of the 
two fidelity measures created only centered on the patient care 
process and did not address philosophy of practice or practice 
management which are core tenets of CMM.  
 
The implementation of CMM within University of Utah Health 
is still ongoing. Future work in CMM implementation will 
include assessment and improvement in practice management, 
additional means of testing fidelity to the patient care process 
and expanding coaching as a means to enhance adoption and 
fidelity by individual clinical pharmacists. Further efforts will be 
needed to demonstrate positive clinical, financial and 
humanistic outcomes from CMM adoption, with specific 
emphasis on cost-savings assessments of those receiving CMM 
by PPCS clinical pharmacists compared to those not receiving 
the service in collaboration with local payers.  
 
Conclusion  
Implementation of a CMM process within University of Utah 
Health’s primary care clinical pharmacy services with the help 
of a national collaborative yielded identification of 17,953 MTPs 
over 18 months and foundational fidelity to core principles. 
Further refinement of CMM implementation is needed to 
increase understanding, utilization and consistency.  
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Figure 1: Implementation Timeline 
 
CMM: Comprehensive medication management; EMR: Electronic medical record; MTP: Medication therapy problem 
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Table 1: Patient Care Process Questionnaire 
During a patient initial comprehensive medication review, do you do the following 
> 80% of the time? (N=15)  
Yes No 
Inquire about patient’s alcohol, tobacco, caffeine use?  53% 47% 
Inquire about immunizations?  80% 20% 
Obtain and document a complete medication list?  100% 0% 
Gather past medication history?  80% 20% 
Inquire about ability to access medications?  100% 0% 
Inquire as to whether the patient independently manages medications or has help at 
home?  
93% 
 
7% 
 
Inquire how the process of managing medications works at home (e.g. pillboxes, 
calendars, reminders)? 
93% 
 
7% 
 
Inquire about adherence to medications?  100% 0% 
 
  
0
10
20
30
40
50
60
70
80
Indication Effectiveness Safety Adherence Assess each step in
order
P
er
ce
n
ta
ge
 o
f 
re
sp
o
n
se
s
Figure 3: Frequency of Assessing Each Step of Patient Care Process (N=15)
Sometimes Often Always
Clinical Experience PHARMACY PRACTICE 
 
http://z.umn.edu/INNOVATIONS                         2020, Vol. 11, No. 2, Article 1                      INNOVATIONS in pharmacy 
                                                                             DOI: https://doi.org/10.24926/iip.v11i2.3002 
8 
 
Appendix A: PPCS Clinical Pharmacist Questionnaire 
 
Q1.  
How many years of practice experience do you have in ambulatory care? 
 
Q2.  
What year did you graduate from pharmacy school? 
 
Q3.  
Did you complete a PGY-1 residency? 
Did you complete a PGY-2 residency? 
Have you ever practiced ambulatory clinical pharmacy at another institution? 
 
Q4.  
What was your PGY-2 specialty? 
 
Q5. 
Please check what board certifications do you currently hold? 
 
Q6.  
Without looking at other resources, how would you personally define the CMM patient care process? 
 
Q7. 
How has the implementation of the CMM patient care process benefited your practice? 
 
Q8. 
What barriers have you encountered in the implementation of the CMM patient care process? 
 
Q9. 
When conducting an initial visit for a comprehensive medication review, do you do the following >80% of the time: 
 Inquire about use of alcohol, tobacco, and caffeine? 
 Inquire about immunizations? 
 Obtain and document a complete medication list that includes nonprescription medications? 
 Gather past medication history? 
 Inquire about the patient’s ability to access medications (e.g., ability to pick up or afford medications)? 
 Inquire as to whether the patient independently manages his/her medications, or if they have help at home? 
 Inquire as to how the process of managing medications works at home (e.g., pill boxes, calendars, reminders)? 
 Inquire about the patient’s adherence to his/her medications? 
 
Q10. 
Please answer the following questions regarding initial patient visits: 
 
Likert scale: 
Never --- Seldom --- Sometimes --- Often --- Always 
 
 How often do you assess the indication of EACH medication the patient is taking? 
 How often do you assess the effectiveness (i.e. meeting clinical goals, appropriate monitoring, etc) of EACH 
medication each patient is taking? 
 How often do you assess the safety (i.e adverse events, drug interactions) of EACH medication the patient is 
taking? 
 How often do you assess the adherence (i.e. access, affordability, missing doses, etc.) of EACH medication the 
patient is taking? 
 How often do you complete the previous four steps in THAT ORDER (indication, effectiveness, safety, adherence)? 
 How often do you formulate and document medication therapy problems in EPIC as I-vents, classifying the 
patient’s medication therapy problems based on indication, effectiveness, safety, and adherence? 
 How often are you able to resolve the identified medication therapy problems? 
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Q11. 
If frequently unable to resolve the MTP, what is the main barrier to resolution? 
 
Q12. 
What questions do you have about CMM at this point? 
 
Q13. 
What would you like to know more about regarding CMM? 
 
